Evidence for involvement of spinal RANTES in the antinociceptive effects of triptolide, a diterpene triepoxide, in a rat model of bone cancer pain.
|
| Abstract |
It has been shown that triptolide has beneficial effects in the treatment of neuropathic pain, but its effects on bone cancer pain (BCP) remain unclear. In this study, we aimed to explore the potential role of spinal regulated activation of normal T cell expressed and secreted (RANTES) in the antinociceptive effects of triptolide on BCP. A BCP model was induced by injecting Walker 256 mammary gland carcinoma cells into the intramedullary space of rat tibia. Intrathecal administration of triptolide (0.5, 1, 2 μg) could dose-dependently alleviate mechanical hyperalgesia and spontaneous pain. In addition, there were also concomitant decreases in RANTES mRNA and protein expression levels in spinal dorsal horn. These results suggest that the antinociceptive effects of triptolide are related with inhibition of spinal RANTES expression in BCP rats. The findings of this study may provide a promising drug for the treatment of BCP.
|
|---|---|
| Authors | Li-Hua Hang, Shu-Na Li, Dong-Hua Shao, Zheng Chen, Yuan-Feng Chen, Wei-Wei Shu |
| Journal | Basic & clinical pharmacology & toxicology (Basic Clin Pharmacol Toxicol) Vol. 115 Issue 6 Pg. 477-80 (Dec 2014) ISSN: 1742-7843 [Electronic] England |
| PMID | 24810483 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't) |
| Copyright | © 2014 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society). |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!